Kaufmann, Scott H <br/><br/>
Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia.  [electronic resource] 

 -  Haematologica  Nov 2011 
 - 1619-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2011.049551  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Benzoquinones--administration & dosage<br/>Checkpoint Kinase 1<br/>Cytarabine--administration & dosage<br/>Female<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Lactams, Macrocyclic--administration & dosage<br/>Leukemia--drug therapy<br/>Male<br/>Middle Aged<br/>Protein Kinases--metabolism<br/>Recurrence<br/>Time Factors